Hannah A. Valantine
#159,795
Most Influential Person Now
Hannah A. Valantine's AcademicInfluence.com Rankings
Hannah A. Valantinephilosophy Degrees
Philosophy
#9176
World Rank
#12696
Historical Rank
Logic
#6166
World Rank
#7654
Historical Rank

Hannah A. Valantinebiology Degrees
Biology
#12551
World Rank
#16034
Historical Rank
Molecular Biology
#2051
World Rank
#2083
Historical Rank

Download Badge
Philosophy Biology
Why Is Hannah A. Valantine Influential?
(Suggest an Edit or Addition)Hannah A. Valantine's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate Mofetil Investigators. (1998) (591)
- Increased beta-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy. (1989) (480)
- Intracoronary Ultrasound in Cardiac Transplant Recipients: In Vivo Evidence of “Angiographically Silent” Intimal Thickening (1991) (477)
- Gene-expression profiling for rejection surveillance after cardiac transplantation. (2010) (418)
- Multicenter intravascular ultrasound validation study among heart transplant recipients: outcomes after five years. (2005) (383)
- Circulating Cell-Free DNA Enables Noninvasive Diagnosis of Heart Transplant Rejection (2014) (377)
- Temporal Response of the Human Virome to Immunosuppression and Antiviral Therapy (2013) (361)
- Topic choice contributes to the lower rate of NIH awards to African-American/black scientists (2019) (319)
- Universal noninvasive detection of solid organ transplant rejection (2011) (316)
- Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis: a post hoc analysis of a randomized, placebo-controlled study. (1999) (287)
- Cardiac allograft vasculopathy after heart transplantation: risk factors and management. (2004) (259)
- National Institutes of Health addresses the science of diversity (2015) (251)
- Noninvasive monitoring of infection and rejection after lung transplantation (2015) (249)
- Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients. (2005) (227)
- Reducing Implicit Gender Leadership Bias in Academic Medicine With an Educational Intervention (2016) (214)
- Prevalence of accelerated coronary artery disease in heart transplant survivors. Comparison of cyclosporine and azathioprine regimens. (1989) (201)
- Prognostic importance of intimal thickness as measured by intracoronary ultrasound after cardiac transplantation. (1995) (187)
- Cardiac allograft vasculopathy: central role of endothelial injury leading to transplant “atheroma” (2003) (179)
- Incidence and progression of transplant coronary artery disease over 1 year: results of a multicenter trial with use of intravascular ultrasound. Multicenter Intravascular Ultrasound Transplant Study Group. (1995) (160)
- Incidence and severity of transplant coronary artery disease early and up to 15 years after transplantation as detected by intravascular ultrasound. (1995) (159)
- Coronary heart disease in African Americans. (2001) (156)
- Induction of nitric oxide synthase in the human cardiac allograft is associated with contractile dysfunction of the left ventricle. (1996) (155)
- Impact of proximal or midvessel discrete coronary artery stenoses on survival after heart transplantation. (1992) (152)
- Wound Healing Complications with De Novo Sirolimus Versus Mycophenolate Mofetil‐Based Regimen in Cardiac Transplant Recipients (2006) (150)
- Cytomegalovirus Infection Impairs the Nitric Oxide Synthase Pathway: Role of Asymmetric Dimethylarginine in Transplant Arteriosclerosis (2004) (150)
- Acute Rejection and Cardiac Allograft Vascular Disease Is Reduced by Suppression of Subclinical Cytomegalovirus Infection (2006) (149)
- Significant reduction in the number of fungal infections after lung-, heart-lung, and heart transplantation using aerosolized amphotericin B prophylaxis. (1997) (146)
- IMPACT OF CYTOMEGALOVIRUS HYPERIMMUNE GLOBULIN ON OUTCOME AFTER CARDIOTHORACIC TRANSPLANTATION: A Comparative Study of Combined Prophylaxis with CMV Hyperimmune Globulin Plus Ganciclovir Versus Ganciclovir Alone (2001) (144)
- Single-stranded DNA library preparation uncovers the origin and diversity of ultrashort cell-free DNA in plasma (2015) (141)
- Metabolic Abnormalities Characteristic of Dysmetabolic Syndrome Predict the Development of Transplant Coronary Artery Disease: A Prospective Study (2001) (138)
- A hemodynamic and Doppler echocardiographic study of ventricular function in long-term cardiac allograft recipients. Etiology and prognosis of restrictive-constrictive physiology. (1989) (138)
- Acute myocardial infarction in cardiac transplant recipients. (1989) (122)
- Changes in Doppler echocardiographic indexes of left ventricular function as potential markers of acute cardiac rejection. (1987) (108)
- Frequency and mechanism of bradycardia in cardiac transplant recipients and need for pacemakers. (1991) (107)
- Molecular testing in the management of cardiac transplant recipients: initial clinical experience. (2006) (106)
- Serial measurement of integrated ultrasonic backscatter in human cardiac allografts for the recognition of acute rejection. (1990) (105)
- T-Cell Immunity to Subclinical Cytomegalovirus Infection Reduces Cardiac Allograft Disease (2006) (105)
- Progression of systemic disease and reduced long-term survival in patients with cardiac amyloidosis undergoing heart transplantation. Follow-up results of a multicenter survey. (1991) (103)
- Recovery of the right ventricle after single-lung transplantation in pulmonary hypertension. (1994) (102)
- The Role of Viruses in Cardiac Allograft Vasculopathy (2004) (102)
- Mycophenolate Mofetil Reduces Intimal Thickness by Intravascular Ultrasound After Heart Transplant: Reanalysis of the Multicenter Trial (2006) (100)
- Severe tricuspid regurgitation after heart transplantation. (2001) (97)
- Cytomegalovirus-associated allograft rejection in heart transplant patients (2007) (89)
- Differentially Expressed RNA from Public Microarray Data Identifies Serum Protein Biomarkers for Cross-Organ Transplant Rejection and Other Conditions (2010) (87)
- Cardiac sarcoidosis: response to steroids and transplantation. (1987) (86)
- Multidisciplinary insights on clinical guidance for the use of proliferation signal inhibitors in heart transplantation. (2008) (85)
- Detection and treatment of coronary artery disease in liver transplant candidates (2001) (84)
- Sensitivity and specificity of diastolic indexes for rejection surveillance: temporal correlation with endomyocardial biopsy. (1991) (79)
- From the NIH: A Systems Approach to Increasing the Diversity of the Biomedical Research Workforce (2016) (79)
- Prevention of Post‐transplant Cardiovascular Disease – Report and Recommendations of an Ad Hoc Group 1 (2002) (77)
- Discordant changes in epicardial and microvascular coronary physiology after cardiac transplantation: Physiologic Investigation for Transplant Arteriopathy II (PITA II) study. (2006) (77)
- Coronary artery intimal thickening in the transplanted heart. An in vivo intracoronary untrasound study of immunologic and metabolic risk factors. (1996) (75)
- Prophylactic ganciclovir treatment reduces fungal as well as cytomegalovirus infections after heart transplantation. (1995) (72)
- Left ventricular diastolic function. Doppler echocardiographic changes soon after cardiac transplantation. (1990) (71)
- Analysis of survivors more than 10 years after heart transplantation in the cyclosporine era: Stanford experience. (2004) (71)
- Nitroglycerin‐Induced Coronary Vasodilation in Cardiac Transplant Recipients: Evaluation With In Vivo Intracoronary Ultrasound (1992) (70)
- Cell-Free DNA to Detect Heart Allograft Acute Rejection. (2021) (69)
- Changing the culture of academic medicine to eliminate the gender leadership gap: 50/50 by 2020. (2013) (68)
- Safety, tolerability, and efficacy of cyclosporine microemulsion in heart transplant recipients: a randomized, multicenter, double-blind comparison with the oil-based formulation of cyclosporine--results at 24 months after transplantation. (1999) (66)
- The Gender Gap in Academic Medicine: Comparing Results From a Multifaceted Intervention for Stanford Faculty to Peer and National Cohorts (2014) (66)
- Donor-derived cell-free DNA predicts allograft failure and mortality after lung transplantation (2019) (66)
- An Integrated Career Coaching and Time-Banking System Promoting Flexibility, Wellness, and Success: A Pilot Program at Stanford University School of Medicine (2018) (63)
- Effect of cyclosporine on plasma endothelin levels in humans after cardiac transplantation. (1991) (63)
- Metabolic risk factors for atherosclerosis in heart transplant recipients. (1994) (62)
- Feasibility of serial intracoronary ultrasound imaging for assessment of progression of intimal proliferation in cardiac transplant recipients. (1994) (62)
- Invasive Assessment of Coronary Physiology Predicts Late Mortality After Heart Transplantation (2016) (62)
- Late manifestation of alloantibody-associated injury and clinical pulmonary antibody-mediated rejection: Evidence from cell-free DNA analysis. (2018) (61)
- Influence of graft rejection on incidence of accelerated graft coronary artery disease: a new approach to analysis. (1993) (61)
- Frequency of familial nature of dilated cardiomyopathy and usefulness of cardiac transplantation in this subset. (1989) (60)
- Proliferation signal inhibitors in transplantation: questions at the cutting edge of everolimus therapy. (2007) (60)
- Influence of recipient atrial contraction on left ventricular filling dynamics of the transplanted heart assessed by Doppler echocardiography. (1987) (60)
- De novo mutations in mitochondrial DNA of iPSCs produce immunogenic neoepitopes in mice and humans (2019) (60)
- Decisions, decisions: how program diversity influences residency program choice. (2011) (59)
- Does acute rejection correlate with the development of transplant coronary artery disease? A multicenter study using intravascular ultrasound. Sandoz/CVIS Investigators. (1995) (58)
- Women in Academic Medicine: Measuring Stereotype Threat Among Junior Faculty. (2016) (57)
- Diabetes and dyslipidemia. A new model for transplant coronary artery disease. (1998) (57)
- Successful intermediate-term outcome for patients with cardiac amyloidosis undergoing heart transplantation: results of a multicenter survey. (1990) (56)
- The SIRPα–CD47 immune checkpoint in NK cells (2021) (55)
- Calcineurin Inhibitors and Post-Transplant Hyperlipidaemias (2001) (54)
- Changes in coronary anatomy and physiology after heart transplantation. (2007) (53)
- Quantification of transplant-derived circulating cell-free DNA in absence of a donor genotype (2017) (52)
- Neoral use in the cardiac transplant recipient. (2000) (51)
- The impact of brain death on survival after heart transplantation: time is of the essence (2003) (51)
- Role of lipids in allograft vascular disease: a multicenter study of intimal thickening detected by intravascular ultrasound. (1995) (50)
- Exercise echocardiography in heart transplant recipients: a comparison with angiography and intracoronary ultrasonography. (1994) (50)
- Outcome in Cardiac Recipients of Donor Hearts With Increased Left Ventricular Wall Thickness (2007) (50)
- Improving outcomes in heart transplantation: the potential of proliferation signal inhibitors. (2005) (49)
- Changes in Coronary Arterial Dimensions Early After Cardiac Transplantation (2007) (48)
- Molecular testing for long-term rejection surveillance in heart transplant recipients: design of the Invasive Monitoring Attenuation Through Gene Expression (IMAGE) trial. (2007) (48)
- Angiotensin-Converting Enzyme Inhibition Early After Heart Transplantation. (2017) (47)
- Everolimus (certican) in heart transplantation: optimizing renal function through minimizing cyclosporine exposure. (2005) (47)
- Increasing pericardial effusion in cardiac transplant recipients. (1989) (46)
- Glucose intolerance, as reflected by hemoglobin A1c level, is associated with the incidence and severity of transplant coronary artery disease. (2004) (46)
- Changing trends in infectious disease in heart transplantation. (2010) (46)
- Intracoronary ultrasound imaging in heart transplant recipients: the Stanford experience. (1992) (46)
- Scedosporium apiospermum (Pseudallescheria boydii) infection in a heart transplant recipient: a case of mistaken identity. (1998) (45)
- Cardiac transplantation in patients with preexisting neoplastic diseases. (1990) (45)
- Cost containment: coadministration of diltiazem with cyclosporine after heart transplantation. (1992) (43)
- Induction Therapy for Pediatric and Adult Heart Transplantation: Comparison Between OKT3 and Daclizumab (2005) (42)
- Is there a role for proliferation signal/mTOR inhibitors in the prevention and treatment of de novo malignancies after heart transplantation? Lessons learned from renal transplantation and oncology. (2007) (42)
- From clinical trials to clinical practice: an overview of Certican (everolimus) in heart transplantation. (2005) (41)
- Twenty‐Year Survivors of Heart Transplantation at Stanford University (2008) (40)
- Applying rigor and reproducibility standards to assay donor-derived cell-free DNA as a non-invasive method for detection of acute rejection and graft injury after heart transplantation. (2017) (40)
- Cardiac allograft vascular disease. Relationship to microvascular cell surface markers and inflammatory cell phenotypes on endomyocardial biopsy. (1995) (40)
- Safety, tolerability and efficacy of cyclosporine microemulsion in heart transplant recipients: a randomized, multicenter, double-blind comparison with the oil based formulation of cyclosporine--results at six months after transplantation. (1999) (39)
- Effect of rapamycin therapy on coronary artery physiology early after cardiac transplantation. (2008) (34)
- Volume-mediated pulmonary responses in liver transplant candidates. (1996) (33)
- Prevention and treatment of cytomegalovirus disease in thoracic organ transplant patients: evidence for a beneficial effect of hyperimmune globulin. (1995) (33)
- Identification and Classification of Acute Cardiac Rejection by Intragraft Transcriptional Profiling (2011) (32)
- Clinical outcome of interval cadaveric renal transplantation in cardiac allograft recipients. (1995) (31)
- Utility of Gene Expression Profiling Score Variability to Predict Clinical Events in Heart Transplant Recipients (2014) (31)
- Transdisciplinary translational science and the case of preterm birth (2012) (29)
- Heart transplantation in patients over 54 years of age. Mortality, morbidity and quality of life. (1997) (29)
- Frequent Occult Infection with Cytomegalovirus in Cardiac Transplant Recipients despite Antiviral Prophylaxis (2007) (29)
- Prevention of cardiac allograft vasculopathy with Certican (everolimus): the Stanford University experience within the Certican Phase III clinical trial. (2005) (28)
- Right ventricular dysfunction predicts poor outcome following hemodynamically compromising rejection. (2009) (28)
- Role of CMV in transplant coronary artery disease and survival after heart transplantation. (1999) (28)
- Doppler echocardiographic indices of diastolic function as markers of acute cardiac rejection. (1987) (28)
- Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: a comparative study. (1997) (27)
- Proliferation signal inhibitors and post‐transplant malignancies in heart transplantation: practical clinical management questions (2011) (27)
- The relationship of granzyme A and perforin expression to cardiac allograft rejection and dysfunction. (1995) (27)
- Identification of Common Blood Gene Signatures for the Diagnosis of Renal and Cardiac Acute Allograft Rejection (2013) (27)
- Early Doppler echocardiographic dysfunction is associated with an increased mortality after orthotopic cardiac transplantation. (1996) (26)
- Cytokine gene expression in human cardiac allograft recipients. (1994) (26)
- Designing a physician leadership development program based on effective models of physician education (2017) (26)
- Recent advances in cardiac transplantation. (1995) (26)
- Paradoxical Vessel Remodeling of the Proximal Segment of the Left Anterior Descending Artery Predicts Long-Term Mortality After Heart Transplantation. (2015) (26)
- Detection of early atherosclerosis with radiolabeled monocyte chemoattractant protein-1 in prediabeteic Zucker rats (2001) (24)
- Circulating cell-free DNA as a biomarker of tissue injury: Assessment in a cardiac xenotransplantation model. (2018) (24)
- Importance of decreased heart rate in predicting transplant coronary artery disease. (1997) (24)
- Distribution and morphologic features of coronary artery disease in cardiac allografts: an intracoronary ultrasound study. (1995) (24)
- New developments in immunosuppressive therapy for heart transplantation (2009) (24)
- Impact of Donor-Transmitted Atherosclerosis on Early Cardiac Allograft Vasculopathy: New Findings by Three-Dimensional Intravascular Ultrasound Analysis (2011) (24)
- Asymmetric Dimethylarginine and Cardiac Allograft Vasculopathy Progression: Modulation by Sirolimus (2008) (24)
- Coronary Endothelial Dysfunction and the Index of Microcirculatory Resistance as a Marker of Subsequent Development of Cardiac Allograft Vasculopathy. (2017) (23)
- The impact of cyclosporine dose and level on the development and progression of allograft coronary disease. Sandoz/CVIS Investigators. (1995) (23)
- Changes in cardiac morphology and function following single-lung transplantation. (1991) (23)
- Interplay between systemic inflammation and markers of insulin resistance in cardiovascular prognosis after heart transplantation. (2007) (22)
- Use of the implantable cardioverter-defibrillator in long-term survivors of orthotopic heart transplantation. (2005) (22)
- Recurrence of amyloid in a cardiac allograft four months after transplantation. (1989) (21)
- Correlation of donor characteristics with transplant coronary artery disease as assessed by intracoronary ultrasound and coronary angiography. (1995) (21)
- Monitoring Pharmacologically Induced Immunosuppression by Immune Repertoire Sequencing to Detect Acute Allograft Rejection in Heart Transplant Patients: A Proof-of-Concept Diagnostic Accuracy Study (2015) (21)
- Attenuated-Signal Plaque Progression Predicts Long-Term Mortality After Heart Transplantation: IVUS Assessment of Cardiac Allograft Vasculopathy. (2016) (20)
- Validation of a screening protocol for identifying low‐risk candidates with type 1 diabetes mellitus for kidney with or without pancreas transplantation (2006) (20)
- Variability of Doppler echocardiographic indexes of left ventricular filling in transplant recipients and in normal subjects. (1990) (20)
- Longer-term risks associated with 10-year survival after heart transplantation in the cyclosporine era. (2003) (20)
- Mycophenolic acid concentrations in long‐term heart transplant patients: relationship with calcineurin antagonists and acute rejection (2002) (19)
- Transplant Coronary Artery Disease: A Novel Model Independent of Cellular Alloimmune Response (2001) (19)
- HMG-CoA reductase inhibitors reduce transplant coronary artery disease and mortality: evidence for antigen-independent mechanisms? (1997) (18)
- Gene Expression Profiling to Study Racial Differences after Heart Transplantation (2015) (18)
- Impact of cyclosporine dose on long-term outcome after heart transplantation. (1994) (17)
- Increased rejection in gender-mismatched grafts: amelioration by triple therapy. (1991) (16)
- The role of complement‐fixing donor‐specific antibodies identified by a C1q assay after heart transplantation (2017) (16)
- Granulocyte colony-stimulating factor therapy is associated with a reduced incidence of acute rejection episodes or allograft vasculopathy in heart transplant recipients. (2013) (16)
- Applications of genetic-epigenetic tissue mapping for plasma DNA in prenatal testing, transplantation and oncology (2021) (15)
- NIH's scientific approach to inclusive excellence (2020) (14)
- Giant coronary aneurysms in heart transplantation: an unusual presentation of cardiac allograft vasculopathy. (2006) (14)
- Post-operative conversion from cyclosporine to tacrolimus in heart transplantation: a single-center experience. (2003) (14)
- Cardiac allograft vasculopathy and insulin resistance--hope for new therapeutic targets. (2007) (13)
- Utility of Gene Expression Profiling Score Variability to Predict Clinical Events in Heart Transplant Recipients. (2014) (13)
- Safety and efficacy of everolimus (RAD) as part of a triple immunosuppressive regimen in de novo cardiac transplant recipients: six-month analysis (2002) (13)
- Further analysis of the intravascular ultrasound data from the randomized mycophenolate mofetil (MMF) trial in heart transplant recipients (2004) (12)
- Where Are We in Bridging the Gender Leadership Gap in Academic Medicine? (2020) (12)
- Conversion of cyclosporine to tacrolimus for refractory or persistent myocardial rejection. (2002) (12)
- Intracoronary ultrasound evaluation of intimal thickening in cardiac transplant recipients: Correlation with clinical characteristics (1991) (12)
- Transplant Coronary Disease (1991) (12)
- Women in science: Women’s work (2013) (11)
- Three-Year Allograft Vasculopathy Results of the Multicenter Heart Transplant Mycophenolate Mofetil Randomized Trial (1999) (10)
- Detection of accelerated graft atherosclerosis importance of hemodynamic response to exercise (1988) (10)
- Early invasive assessment of the coronary microcirculation predicts subsequent acute rejection after heart transplantation. (2019) (10)
- Survivors more than 10 years after heart transplantation in the cyclosporine era (2002) (10)
- Recurrence of iron deposition in the cardiac allograft in a patient with non-HFE hemochromatosis. (2006) (10)
- Pulmonary nocardiosis in a heart transplant patient: case report and review of the literature. (2007) (9)
- Donor derived cell free DNA% is elevated with pathogens that are risk factors for acute and chronic lung allograft injury. (2021) (9)
- Long-term management and results in heart transplant recipients. (1990) (9)
- Individualizing immunosuppression for heart transplantation: strategies for the next decade. (1997) (8)
- Prognosis of patients with significant angiographically diagnosed cardiac allograft coronary disease (2002) (8)
- Cytokines as potential mediators of acute allograft diastolic dysfunction in cyclosporine-treated patients: a pilot study using in situ hybridization. (1994) (8)
- Towards Equity in Health: Researchers Take Stock (2016) (8)
- Peripheral Blood Leukocyte Counts in Cytomegalovirus Infected Heart Transplant Patients: Impact of Acute Disease Versus Subclinical Infection (2006) (7)
- Mild hyperhomocysteinemia is not associated with cardiac allograft coronary disease (2001) (7)
- Cardiac function after domino-donor heart transplantation. (1992) (7)
- Reversal of diabetes-induced rat graft transplant coronary artery disease by metformin. (2002) (7)
- Academic couples: implications for medical school faculty recruitment and retention. (2011) (7)
- Medical Faculty Development: A Modern-Day Odyssey (2011) (7)
- Association of Endothelin-1 With Accelerated Cardiac Allograft Vasculopathy and Late Mortality Following Heart Transplantation. (2019) (7)
- NIH progress toward inclusive excellence (2020) (7)
- 50 Years to Gender Parity: Can STEM Afford to Wait?: A Cardiologist and NIH Chief Officer of Scientific Workforce Diversity Reflects on What It Will Take to Keep Women in Biomedicine (2017) (6)
- Does late switch to mycophenolate mofetil affect development of transplant coronary artery disease (2002) (5)
- Pulled in Too Many Directions: The Causes and Consequences of Work-Work Conflict (2018) (5)
- Long-term prognostic value of invasive and non-invasive measures early after heart transplantation. (2018) (5)
- Higher levels of allograft injury in black patients early after heart transplantation. (2021) (5)
- Multi-center intravascular ultrasound validation study among heart transplant recipients: outcomes after 5 years (2004) (5)
- Rejection surveillance by Doppler echocardiography. (1993) (5)
- Transcriptomics in transplantation: More than just biomarkers of allograft rejection (2020) (5)
- Cytomegalovirus infection and allograft injury (2001) (5)
- NIH's Essential 21st-Century Research Challenge: Enhancing Scientific Workforce Diversity. (2016) (4)
- Teaching Corporate in College (2014) (4)
- Conversion of cyclosporine to tacrolimus in heart transplant patients: a single center experience (2002) (4)
- 469 Correlation of Cytomegalovirus (CMV) Serologic Status of Heart Transplant Recipients to Gene-Expression Profiling Scores and Clinical Outcomes: Results from the IMAGE Multicenter Study (2012) (4)
- How to Recognize and Address Unconscious Bias (2020) (4)
- The effect of negative remodeling on fractional flow reserve after cardiac transplantation. (2017) (4)
- Circulating microRNAs in cellular and antibody-mediated heart transplant rejection. (2022) (4)
- Mild cardiac allograft coronary disease does not change the prognosis of patients after heart transplantation (2002) (3)
- Workforce Diversity and Capacity Building to Address Health Disparities (2021) (3)
- Non-Invasive Monitoring of Infection and Rejection After Lung Transplantation (2015) (3)
- PLASMA CELL-FREE DNA AS A NOVEL MARKER OF DISEASE SEVERITY IN PULMONARY ARTERIAL HYPERTENSION (2019) (3)
- MYCOPHENOLATE MOFETIL IS ASSOCIATED WITH LESS CARDIAC TRANSPLANT REJECTION THAN AZATHIOPRINE IN PATIENTS WITH RECURRENT REJECTIONS (1999) (3)
- Genomic Research Alliance for Transplantation (GRAfT): A Model for Long Term Transplant Studies in Thoracic Organ Transplantation (2016) (3)
- Precision of a Novel High-Definition 60MHz IVUS in Quantitative Measurement: Comparison with Conventional 40MHz IVUS and Optical Coherence Tomography (2014) (3)
- Everyday Heroism: Maintaining Organizational Cultures of Wellness and Inclusive Excellence Amid Simultaneous Pandemics (2020) (3)
- Racial Disparities after Heart Transplant: Evidence from IMAGE (2013) (3)
- Hyperhomocysteinemia Is Common In Heart Transplant Patients But Is Not Correlated With Transplant Coronary Artery Disease (1999) (3)
- Determinants of Lumen Loss Between Years 1 and 2 After Cardiac Transplantation (2007) (2)
- Cytomegalovirus and heart transplant atherosclerosis: a likely guilt hidden by weak proofs. (2004) (2)
- Cytomegalovirus and Development of Cardiac Allograft Vasculopathy: Evidences and Therapeutic Implications (2010) (2)
- Attenuated-Signal Plaque Progression Predicts Long-Term Mortality After HeartTransplantation (2016) (2)
- Circulating Cell-Free DNA Is a Non-Invasive Marker of Heart Transplant Rejection (2014) (2)
- (148) - Early Graft Injury Measured by Donor-Derived Cell-Free DNA Predicts Early Mortality in Lung Transplant Recipients (2017) (2)
- 157: Early detection of cardiac allograft vasculopathy through gene expression profiling – insights of the CARGO study (2006) (2)
- Economic Impact of Monitoring Heart Transplant Recipients With Gene Expression Profiling to Detect Rejection: an IMAGE Analysis. (2010) (2)
- Resolution of restrictive physiology following cardiac allograft rejection: An indicator of resolved rejection (1990) (2)
- Ending Sexual Harassment in Science: Designing and Administering a Survey That Can Lead to an Improved Organizational Climate (2021) (2)
- Elevated Donor-Derived Cell-Free DNA (ddcfDNA) as an Early Risk Factor for the Development and Persistence of De Novo Donor Specific HLA Antibody (2018) (2)
- A giant leap for womankind (2019) (2)
- Policy: NIH push to stop sexual harassment (2016) (2)
- Impact of Asymmetric Dimethylarginine on Coronary Physiology Early After Heart Transplantation. (2017) (2)
- (1219) - Association Between LVAD and Cardiac Allograft Injury Following Heart Transplantation as Assessed by Cell-Free DNA (2017) (2)
- Everolimus is associated with a reduced incidence of CMV infection in heart transplantation (2003) (2)
- Elevated cell‐free DNA in respiratory viral infection and associated lung allograft dysfunction (2022) (2)
- Plasma Cell-Free DNA Predicts Survival and Maps Specific Sources of Injury in Pulmonary Arterial Hypertension (2022) (2)
- [Coronary allograft vasculopathy: pathophysiological interaction between the immune system, infections and metabolic syndrome]. (2007) (2)
- Science Has a Gender Problem. (2016) (2)
- Validation of Donor-derived Cell-free DNA to Detect Heart-transplant Rejection (2018) (2)
- Donor Derived Cell Free DNA is Elevated With Pathogens That are Risk Factors For Chronic Lung Allograft Dysfunction (2018) (1)
- Genetic-epigenetic tissue mapping for plasma DNA: applications in prenatal testing, transplantation and oncology (2020) (1)
- Immune mediators of acute cardiac allograft dysfunction (1991) (1)
- Preferential involvement of larger vessels in a rat model of diabetes-induced graft vasculopathy. (2002) (1)
- Abstract 2411: The Importance of Right Ventricular Dysfunction in patients with Hemodynamically Compromising Rejection (2008) (1)
- Donor-derived mitochondrial DNA variant peptides elicit allo-specific immune response in transplant patients (2020) (1)
- ANGIOTENSIN-CONVERTING ENZYME INHIBITION EARLY AFTER CARDIAC TRANSPLANTATION: A MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND TRIAL COMPARING RAMIPRIL VERSUS PLACEBO (2016) (1)
- Cardiac Allograft Injury in Patients of African Ancestry: Trends of Donor-Derived Cell-Free DNA Based on Genetic Ancestry (2021) (1)
- Is the New ISHLT Criteria for Pulmonary Antibody-mediated Rejection Also a Severity Indicator? (2018) (1)
- Role of dd-cfDNA in Predicting Early Post-operative Course in Lung Transplant Recipients (2018) (1)
- 813-1 Cytomegalovirus infectious burden is proportional to cardiac allograft vasculopathy in heart transplant recipients (2004) (1)
- Utility of Gene Expression Profiling Test Score Stability To Predict Future Clinical Events in Heart Transplant Recipients (2013) (1)
- 162: Sirolimus Use in Heart Transplant Recipients Is Associated with a High Incidence of Adverse Reactions Requiring Drug Discontinuation (2008) (1)
- Frequent Occult Infection with Cytomegalovirus in Cardiac Transplant Recipients despite Antiviral Prophylaxis (2008) (1)
- 20-year survivors of heart transplantation at Stanford University (2009) (1)
- Magnetic resonance imaging-derived parameter of portal flow predicts volume-mediated pulmonary hypertension in liver transplantation candidates. (1995) (1)
- Cardiac transplantation (2004) (1)
- Sirolimus Adverse Event Profile in a Non-Clinical Trial Cohort of Heart Transplantation Patients (2020) (1)
- Predicting Risk of Early Readmission in Lung Transplant Recipients Using dd-cfDNA (2018) (1)
- Allograft Injury and Outcomes in African American Lung Transplant Recipients. (2020) (1)
- Variable Cell-free DNA Characteristics With Different Acute Rejection Phenotypes (2018) (1)
- Advancing the Progress of Mentoring for Diversity in AIDS Research: Warming the Mentoring Climate (2016) (1)
- Antibody-mediated Rejection: Should We Wait for Clinical Diagnosis? (2018) (1)
- 162: Inhibition of cardiac allograft vasculopathy by sirolimus and mycofenolate: Asymmetric dimethyl arginine as a potential therapeutic target (2006) (1)
- Circulating microRNA Biomarkers in Cellular and Antibody-Mediated Heart Transplant Rejection (2022) (1)
- 556 Heart Transplants Are Genome Transplants: Universal Noninvasive Detection of Solid Organ Transplant Rejection (2011) (1)
- Impact of prophylactic immediate post-transplant genciclovir on development of transplant atherosclerosis: A randomized placebo-controlled study (1996) (1)
- Clinically-unrecognized Allograft Injury is Common After Lung Transplantion (2018) (1)
- The Association between Donor-Recipient Race Matching and Survival Following Lung Transplantation Differs Based on Recipient Race (2016) (0)
- Cell-Free DNA to Monitor Immunosuppression Adequacy in Lung Transplantation (2021) (0)
- Doppler and M-Mode Echocardiographic Assessment of Left Ventricular Function during Acute Cardiac Allograft Rejection (1987) (0)
- Circulating cell-free DNA ( cfDNA ) is emerging as a powerful monitoring tool in cancer , pregnancy and organ transplantation (2015) (0)
- Increasing Pericardial Effusion (2005) (0)
- (511) - Pre-Transplant Donor-Recipient Characteristics and the Relationship to Early Cardiac Allograft Injury Measured by Cell-Free DNA (2017) (0)
- 78 Do Longitudinal Stable Lower AlloMap® Scores Portend Better Outcomes after Heart Transplantation? (2011) (0)
- Abstract 2314: Altered Metabolism of Asymetric Dimethylarginine (ADMA) is Associated with Endothelial Dysfunction and Negative Arterial Remodelling After Heart Transplantation (2007) (0)
- (1145) - Mitochondria Energetics Is Significantly Altered During Acute Cellular Rejection in a Rat Transplantation Model (2017) (0)
- Can We Predict Rejection Early After Heart Transplantation? (2021) (0)
- Impact of AMR Treatment: Responders vs Non-Responders Characteristics (2021) (0)
- Usefulness of Asymmetric Dimethylarginine to Predict Outcomes After Heart Transplantation. (2018) (0)
- Abstract 2576: Impact of Donor-transmitted Atherosclerosis on Early Cardiac Allograft Vasculopathy; New Findings by 3-D IVUS (2006) (0)
- 733-4 Induction of Inducible Nitric Oxide Synthase (iNOS) mRNA and Protein in the Human Cardiac Allograft is Associated with Increased Myocardial cGMP Levels and Echocardiographic LV Dysfunction (1995) (0)
- Association between Pretransplant Antibody against Angiotensin II Type 1 Receptor and Posttransplant Allograft Injury. (2020) (0)
- OR20 Nhlbi-sponsored prospective study to validate the use of donor-derived cell-free DNA to detect lung-transplant rejection - interim results (2019) (0)
- IMPACT OF ENDOTHELIN-1 ON CARDIAC ALLOGRAFT VASCULOPATHY, LATE MORTALITY AND RE-TRANSPLANTATION FOLLOWING HEART TRANSPLANTATION (2018) (0)
- 129 Incidence and Predictors of Late Rejection after Cardiac Transplantation (2011) (0)
- Cell-Free DNA Enhances Pathologist Interrater Reliability at the Assessment of Acute Rejection on Endomyocardial Biopsy, on Behalf of the GRAfT Investigators (2023) (0)
- IMPROVEMENT IN RIGHT HEART FAILURE AFTER TRICUSPID VALVE REPLACEMENT IN CARDIAC TRANSPLANT PATIENTS (1999) (0)
- GLUCOSE INTOLERANCE AS REFLECTED BY HEMOGLOBIN A1C IS SIGNIFICANTLY ASSOCIATED WITH A HIGH INCIDENCE OF TRANSPLANT CORONARY ARTERY DISEASE (1999) (0)
- 342 Non-Stenotic Coronary Vasculopathy Is Associated with Reduced Survival after Heart Transplantation (2012) (0)
- Transplant Arteriopathy: Role of Nitric Oxide Synthase (2006) (0)
- Applying Genomics to Unravel Health Disparities in Organ Transplantation: Paul I. Terasaki State-of-the-art Lecture; American Transplant Congress 2021. (2022) (0)
- Characteristics of Urine Cell-Free DNA in Heart and Lung Transplant (2019) (0)
- Tc-99m ISONITRILE SCINTIGRAPHY OFFERS AN IMPROVED NONINVASIVE METHOD FOR ASSESSING SIGNIFICANT TRANSPLANT CORONARY ARTERY VASCULOPATHY (1992) (0)
- 98: Comparison of Gene Expression Profiling and Endomyocardial Biopsy for Surveillance of Acute Cardiac Cellular Rejection: Results from the IMAGE Trial (2010) (0)
- olecular Testing in the Management of Cardiac Transplant ecipients : Initial Clinical Experience (2006) (0)
- Abstract 16130: Early Invasive Assessment of the Coronary Microcirculation Predicts Subsequent Acute Rejection After Heart Transplantation (2016) (0)
- Proceedings of a symposium on individualizing immunosuppression : strategies for the next decade, October 25-26, 1996, Tucson, Arizona (1997) (0)
- Is ultrasound of clinical value in the management of heart transplant patients (1993) (0)
- Early and Late Pulmonary AMR Show Distinct Profiles; Clinical and Epigenetic Analyses. (2020) (0)
- Editorial: Equity in Transplantation: A Commitment for Progress in Troubled Times (2022) (0)
- Appropriate Intravascular Ultrasound Measurement Intervals for Assessment of Cardiac Allograft Vasculopathy after Heart Transplantation (2014) (0)
- Cytomegalovirus burden and progressive severity of cardiac allograft vasculopathy (2004) (0)
- Reproducibility of Genomic Data Using Standards-Cell Free DNA to Monitor Rejection after Heart Transplantation (2016) (0)
- Abstract 14016: The Development of De Novo Anti-hla Antibodies after Heart Transplant is Related to the Development of Rejection Depending of Their Complement Fixing Capability (2012) (0)
- (1228) - Genomic Research Alliance for Transplantation (GRAfT) A Unique Cohort to Address Age, Sex and Race in Heart Transplants (2017) (0)
- The endogenous nitric oxide synthase inhibitor Asymmetric Dimethylarginine (ADMA) predicts cardiac allograft vasculopathy progression (2007) (0)
- Lung Transplant Recipients with Severe Primary Graft Dysfunction Requiring ECMO Had Similar Donor-Derived Cell-Free DNA Levels and Lung Function as Matched Controls. (2020) (0)
- End-stage renal failure and kidney transplantation in heart transplant recipients (2002) (0)
- Author response: Applications of genetic-epigenetic tissue mapping for plasma DNA in prenatal testing, transplantation and oncology (2021) (0)
- Non-stenotic coronary vasculopathy is associated with reduced survival after heart transplantation (2013) (0)
- Abstract 10765: Plasma Cell-Free DNA Predicts Survival and Maps Tissue-Specific Sources of Injury in Pulmonary Arterial Hypertension (2021) (0)
- Abstract 2959: Granulocyte-Colony Stimulating Factor Therapy is Associated with Reduced Incidence of Acute Rejections and Allograft Vasculopathy in Heart Transplant Recipients (2008) (0)
- Cell-Free DNA to Distinguish High Risk Donor Specific Antibodies in Heart Transplantation (2022) (0)
- 238: Progression of mild rejection: Impact on new ISHLT classification (2007) (0)
- Response by Shah et al to Letter Regarding Article, "Cell-Free DNA to Detect Heart Allograft Acute Rejection". (2021) (0)
- TCT-360 Appropriate Intravascular Ultrasound Measurement Intervals for Assessment of Cardiac Allograft Vasculopathy after Heart Transplantation (2014) (0)
- 288: 20-Year Survivors of Heart Transplantation at Stanford University (2009) (0)
- Influence of brain death on survival after heart transplantation - time is of the essence (2002) (0)
- TACROLIMUS IS ASSOCIATED WITH IMPROVED VENTRICULAR SYSTOLIC AND DIASTOLIC CARDIAC ALLOGRAFT FUNCTION: ? DIRECT EFFECT ON MYOCYTE FUNCTION.: Abstract# 699 (2000) (0)
- INVASIVE CORONARY PHYSIOLOGY AT ONE YEAR PREDICTS LATE MORTALITY AFTER HEART TRANSPLANTATION (2015) (0)
- Aggressive anti-cytomegalovirus prophylaxis and acute rejection in high risk patients: Beat the virus and prevent the rejection (2005) (0)
- 185 Impact of Donor and Recipient Sex on Survival and Acute Rejection after Heart Transplantation: Analysis of the ISHLT Database (2011) (0)
- VOLUMETRIC VERSUS PLANAR INTRAVASCULAR ULTRASOUND ANALYSIS TO ASSESS SEVERITY OF CARDIAC ALLOGRAFT VASCULOPATHY (2014) (0)
- Role of cytomegalovirus and asymmetric dimethylarginine in the derangement of nitric oxide synthase in cardiac allograft recipients (2003) (0)
- EARLY CORONARY ENDOTHELIAL DYSFUNCTION PREDICTS ACCELERATED PLAQUE PROGRESSION 1 YEAR AFTER CARDIAC TRANSPLANTATION: SERIAL VOLUMETRIC EVALUATION BY INTRAVASCULAR ULTRASOUND (2016) (0)
- Pulmonary Antibody-Mediated Rejection (AMR) Accelerates Aging-Evidence from Whole Genome DNA Methylation Sequencing (2019) (0)
- Factors associated with long-term survival after heart transplantation in the cyclosporine era (2002) (0)
- 189: Relationship between insulin resistance features and progression of cardiac allograft vasculopathy (2007) (0)
- Echocardiographic Diagnosis of Acute Allograft Rejection (2001) (0)
- Relation between renal function and neointimal tissue characteristics after drug-eluting stent implantation: virtual histology-intravascular ultrasound analysis (2014) (0)
- Abstract 15798: MicroRNA Profiles in Cardiac Transplantation Distinguish Antibody-Mediated and Cellular Rejection (2017) (0)
- (478) – Relationship of Early Lung Allograft Injury as Measured by Cell Free DNA with Donor and Recipient Characteristics (2017) (0)
- Mitochondrial DNA Mismatches in Thoracic Transplantation: Potential Triggers of Allograft Immunogenicity (2019) (0)
- Feasibilit of Serial Intracoronary Ultrasound Imaging for Assessment of Progression of Intimal Proliferation in Cardiac Transplant Recipients (2005) (0)
- Impact of prophylactic OKT3 on mild acute rejection of the cardiac allograft (1990) (0)
- Cell-Free DNA Tissue Damage Mapping in Transplant Patients Infected with COVID-19 (2021) (0)
- The Role of Echocardlography In the FoIIow‐Up of Orthotopic Heart Transplant Patients (1996) (0)
- Increased Cell Free DNA Levels in African American Patients Early after Heart Transplantation. (2020) (0)
- De novo mutations in mitochondrial DNA of iPSCs produce immunogenic neoepitopes in mice and humans (2019) (0)
- Comparative Utility of Gene Expression Profiling Score Variability, Endomyocardial Biopsy, and Echocardiography to Predict Future Clinical Events in Heart Transplant Recipients (2014) (0)
- TCT-818 Early Left Ventricular Dysfunction is Associated with Cardiac Allograft Vasculopathy and Late Mortality After Heart Transplantation. (2016) (0)
- OR53 Post transplant monitoring to include donor derived cell free DNA (%ddcfDNA): Steps toward personalized medicine (2018) (0)
- 525 Prognostic Value of the ISHLT and DGK Working Formulations for Transplant Vasculopathy in Survival after Heart Transplantation (2011) (0)
- Abstract 2965: QT Interval Prolongation during Severe Acute Rejection is Predictive of Sudden Cardiac Death in Heart Transplant Recipients (2008) (0)
- Imaging Intravascular - IVUS (TCT-344 to TCT-364)TCT-351 Attenuated-Signal Plaque and Cardiac Allograft Vasculopathy: A Serial Volumetric IVUS Study of Heart Transplant Recipients (2014) (0)
- Ventricular Function in Long-term Cardiac Allograft Recipients (2005) (0)
- 258: The importance of diabetes, biventricular failure and cellular infiltrates in hemodynamically compromising rejection (2007) (0)
- SAFETY, TOLERABILITY, AND EFFICACY OF CYCLOSPORINE MICROEMULSION IN HEART TRANSPLANT RECIPIENTS: A RANDOMIZED, MULTICENTER, DOUBLE-BLIND COMPARISON WITH THE OIL-BASED FORMULATION OF CYCLOSPORINE—RESULTS AT 24 MONTHS AFTER TRANSPLANTATION1 (2001) (0)
- De Novo Mutations in Mitochondrial DNA of iPSCs Produce Immunogenic Neoepitopes in Humans. (2020) (0)
- To Treat or Not to Treat: DSA Positive Lung Transplant Recipients. (2020) (0)
- Stereotype Threat Survey (2017) (0)
- Novel Model To Assess Prognosis of Transplant Vasculopathy Following Cardiac Transplantation (2013) (0)
- 273: Prevention of subclinical CMV infection reduces cardiac allograft disease progression by positively affecting coronary remodeling (2006) (0)
- A Pioneer in Transplantation Genomics, Inclusion, and Diversity: A Conversation With Hannah Valantine, MBBS, MD. (2021) (0)
- Abstract 2575: Negative Remodeling is Primarily Responsible for Coronary Artery Lumen Loss Early After Cardiac Transplantation: Role of Cytomegalovirus (2006) (0)
- Early Donor-Derived Cell-Free DNA Predicts Peak Allograft Function in Heart Transplant. (2020) (0)
- HIGHER LEVELS OF ASYMMETRIC DIMETHYLARGININE ARE ASSOCIATED WITH LOWER FRACTIONAL FLOW RESERVE AFTER ORTHOTOPIC HEART TRANSPLANTATION (2016) (0)
- Title Towards equity in health : researchers take stock (2016) (0)
- Circulating Xenograft-Derived Cell-Free DNA as a Reliable Marker for Injury After Xenotransplantation (2017) (0)
- Cardiac Allograft Vascular Disease (2020) (0)
- 119 Personalized Clinical Rejection Surveillance after Cardiac Transplantation by Longitudinal Gene Expression Profiling (2011) (0)
- 494: Changing Trends in Infectious Complications among Heart Transplant Recipients (2009) (0)
- Impact of type 1 diabetes on microvascular vs. macrovascular involvement with TXCAD: is there a difference in models of the disease? (2001) (0)
- Circulating, Cell-Free, MicroRNA Sequencing to Diagnose Cardiac Allograft Rejection and Distinguish Rejection Subtype (2019) (0)
- Inflammatory Events Precede Development of De Novo DSA after Lung Transplantation (2019) (0)
- Racial Differences in Immunosuppression and Lung Transplant Outcomes (2021) (0)
- Cfcloud: A Cloud-Based Workflow for Cell-Free DNA Data Analysis (2020) (0)
- Urine Cell-Free Donor-Derived DNA (ucfdDNA) after Heart Transplantation (2016) (0)
- Dysregulated Circulating Proteins in Cellular and Antibody-Mediated Rejection, on Behalf of the Graft Investigators (2023) (0)
- 486: Does the presence of adiposity or the metabolic syndrome in transplant donor or recipient increase the progression of cardiac allograft vasculopathy? (2007) (0)
- THE IMPACT OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS ON ASYMMETRIC DIMETHYLARGININE IN ORTHOTOPIC HEART TRANSPLANTATION RECIPIENTS: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL (2016) (0)
- 468: Microvascular Dysfunction and Suboptimal Glycemic Control Predicts Poor Outcome Following Heart Transplantation (2009) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Hannah A. Valantine?
Hannah A. Valantine is affiliated with the following schools: